Amir Abrishami

Amir Abrishami serves as a Part-Time Assistant Professor in the Department of Anesthesia at McMaster University. His academic appointment reflects active engagement in both clinical anesthesia practice and translational research initiatives.

Research Focus: Dr. Abrishami maintains dual research trajectories spanning traditional anesthesia safety and emerging cancer theranostics. His foundational work centers on medication error prevention in anesthesia, perioperative smoking cessation interventions, and neuromuscular blockade management. Since 2023, he has expanded into nanomedicine with significant publications on metal-organic frameworks and quantum dot systems for colorectal cancer theranostics.

Publication Trends: Analysis of his 15 most recent publications reveals strategic evolution from systematic reviews in anesthesia safety (2006-2021) toward cutting-edge nanotechnology applications (2024-2025). His cancer research focuses on hybrid nanoparticle systems for targeted drug delivery, while maintaining parallel work on ketamine therapies for treatment-resistant depression and pandemic-era airway safety protocols.

Collaborative Networks: Extensive co-authorship patterns indicate strong connections with the Canadian Rapid Treatment Center of Excellence for mental health research and international oncology teams for nanomedicine development. His work shows significant real-world impact with references in clinical guidelines, policy documents, and multiple Wikipedia entries.